147 related articles for article (PubMed ID: 6190596)
21. Inhibition of the proliferative response of peripheral blood lymphocytes to mycobacterial or fungal antigens by co-stimulation with antigens from various mycobacterial species.
Bahr GM; Rook GA; Stanford JL
Immunology; 1981 Nov; 44(3):593-8. PubMed ID: 6459289
[TBL] [Abstract][Full Text] [Related]
22. Suppression of BCG cell wall-induced delayed-type hypersensitivity by pretreatment with killed BCG: induction of nonspecific suppressor T cells by the adjuvant portion (MDP) and of specific suppressor T cells by the antigen portion (TAP).
Kato K; Yamamoto K; Kimura T; Azuma I; Askenase PW
J Immunol; 1984 Jun; 132(6):2790-5. PubMed ID: 6202761
[TBL] [Abstract][Full Text] [Related]
23. Mycobacterium bovis BCG-induced Th1 type CD4+ suppressor T cells act by suppressing IL-2 production and IL-2 receptor expression.
Mustafa AS
Nutrition; 1995; 11(5 Suppl):692-4. PubMed ID: 8748254
[TBL] [Abstract][Full Text] [Related]
24. Accessory cell function of cells of the mononuclear phagocyte system isolated from mycobacterial granulomas.
Gupta S; Curtis J; Turk JL
Cell Immunol; 1985 Apr; 91(2):425-33. PubMed ID: 3888411
[TBL] [Abstract][Full Text] [Related]
25. [Immunosuppression in leprosy].
Sasiain MC; de la Barrera S
Medicina (B Aires); 1989; 49(3):213-5. PubMed ID: 2535042
[TBL] [Abstract][Full Text] [Related]
26. In vitro lymphocyte response to purified protein derivative, BCG and Mycobacterium leprae in a population not exposed to leprosy.
Closs O
Infect Immun; 1975 Jun; 11(6):1163-9. PubMed ID: 1095479
[TBL] [Abstract][Full Text] [Related]
27. T cell responses to fractionated Mycobacterium leprae antigens in leprosy. The lepromatous nonresponder defect can be overcome in vitro by stimulation with fractionated M. leprae components.
Ottenhoff TH; Converse PJ; Gebre N; Wondimu A; Ehrenberg JP; Kiessling R
Eur J Immunol; 1989 Apr; 19(4):707-13. PubMed ID: 2659369
[TBL] [Abstract][Full Text] [Related]
28. Functional analysis of human T cell subsets defined by monoclonal antibodies. VI. Distinct and opposing immunoregulatory functions within the OKT8+ population.
Thomas Y; Rogozinski L; Rabbani L; Chess A; Goldstein G; Chess L
J Mol Cell Immunol; 1984; 1(2):103-13. PubMed ID: 6152892
[TBL] [Abstract][Full Text] [Related]
29. Immunoreactivity of a 70 kD protein purified from Mycobacterium bovis Bacillus Calmette-Guerin by monoclonal antibody affinity chromatography.
Britton WJ; Hellqvist L; Basten A; Inglis AS
J Exp Med; 1986 Sep; 164(3):695-708. PubMed ID: 3528377
[TBL] [Abstract][Full Text] [Related]
30. The suppressive effect of M. leprae on the in vitro proliferative responses of lymphocytes from patients with leprosy.
Nath I; Singh R
Clin Exp Immunol; 1980 Sep; 41(3):406-14. PubMed ID: 7002396
[TBL] [Abstract][Full Text] [Related]
31. Natural suppressor cells in human leprosy: the role of HLA-D-identical peripheral lymphocytes and macrophages in the in vitro modulation of lymphoproliferative responses.
Nath I; Van Rood JJ; Mehra NK; Vaidya MC
Clin Exp Immunol; 1980 Nov; 42(2):203-10. PubMed ID: 6451335
[TBL] [Abstract][Full Text] [Related]
32. Identification of T-cell-activating recombinant antigens shared among three candidate antileprosy vaccines, killed M. leprae, M. bovis BCG, and mycobacterium w.
Mustafa AS
Int J Lepr Other Mycobact Dis; 1988 Jun; 56(2):265-73. PubMed ID: 3045224
[TBL] [Abstract][Full Text] [Related]
33. Antigens of PPD, old tuberculin, and autoclaved Mycobacterium bovis BCG studied by crossed immunoelectrophoresis.
Harboe M
Am Rev Respir Dis; 1981 Jul; 124(1):80-7. PubMed ID: 7020505
[TBL] [Abstract][Full Text] [Related]
34. Comparison of various preparations of Mycobacterium leprae and other mycobacteria by lymphocyte stimulation.
Bjune G
Int J Lepr Other Mycobact Dis; 1978; 46(3-4):386-93. PubMed ID: 83309
[TBL] [Abstract][Full Text] [Related]
35. Bacille Calmette-Guérin vaccination enhances human gamma delta T cell responsiveness to mycobacteria suggestive of a memory-like phenotype.
Hoft DF; Brown RM; Roodman ST
J Immunol; 1998 Jul; 161(2):1045-54. PubMed ID: 9670986
[TBL] [Abstract][Full Text] [Related]
36. HIV type 1 envelope glycoprotein 120 carboxy-terminal peptide-induced human T cell lines selectively suppress heterogeneous proliferative T cell responses to soluble antigens.
Wilson SE; Habeshaw JA; Addawe MA; Hounsell EF; Oxford JS
AIDS Res Hum Retroviruses; 1997 Oct; 13(15):1313-24. PubMed ID: 9339848
[TBL] [Abstract][Full Text] [Related]
37. The immune responses of central and effector memory BCG-specific CD4+ T cells in BCG-vaccinated PPD+ donors were modulated by Treg cells.
Li L; Qiao D; Zhang X; Liu Z; Wu C
Immunobiology; 2011 Apr; 216(4):477-84. PubMed ID: 20950889
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of human lymphoproliferative responses by mycobacterial phenolic glycolipids.
Fournie JJ; Adams E; Mullins RJ; Basten A
Infect Immun; 1989 Nov; 57(11):3653-9. PubMed ID: 2572559
[TBL] [Abstract][Full Text] [Related]
39. Human T cell proliferative responses to particulate microbial antigens are supported by populations enriched in dendritic cells.
Mittal A; Nath I
Clin Exp Immunol; 1987 Sep; 69(3):611-7. PubMed ID: 3311498
[TBL] [Abstract][Full Text] [Related]
40. Genetically restricted suppressor T-cell clones derived from lepromatous leprosy lesions.
Modlin RL; Kato H; Mehra V; Nelson EE; Fan XD; Rea TH; Pattengale PK; Bloom BR
Nature; 1986 Jul 31-Aug 6; 322(6078):459-61. PubMed ID: 2942780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
